Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Richard James Neville

bmj;392/jan29_11/s187/FAF1faRichard was born in Newport, Shropshire, and educated at Adams Grammar School, gaining A levels in classics and […]

January 30, 2026 Uncategorized

Gaps remain in UK’s new child poverty strategy

The UK government published its long awaited child poverty strategy at the end of 2025. It lands amid […]

January 30, 2026 Uncategorized

COPD: New targeted treatment is approved by NICE

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved […]

January 29, 2026 Emergency medicine, General practice / family medicine, UK, Respiratory medicine

Children’s environmental health under siege: the hidden burden of war toxicity in Gaza

Abbasi discusses the medical community’s responsibility to prevent and stop genocide and mentions a recent study finding that […]

January 29, 2026 Uncategorized

CERo reports encouraging early data from phase 1 trial of CER‑1236

CERo reports encouraging early data from phase 1 trial of CER‑1236
p p Read More

CER‑T therapy shows initial safety signals and prompts protocol expansion

January 29, 2026 News

ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray

ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
p p Read More

Trial to assess whether once‑weekly treatment can reduce symptomatic viral respiratory infections

January 29, 2026 News

Europe has greater responsibility in the WHO without the United States

At the upcoming executive board meeting of the World Health Organization (WHO), European countries will need to position […]

January 29, 2026 Uncategorized

Dire state of neurological care in the Gaza Strip

As a neurologist in training, I am compelled to mention the catastrophic situation befalling neurology in the Gaza […]

January 29, 2026 Uncategorized

Argo Biopharma doses first patient in phase 2b trial of BW‑20829

siRNA therapeutic progresses in global study for patients with elevated Lp(a)

January 29, 2026 News

Akari files new patent and advances second ADC targeting CEACAM5

Akari files new patent and advances second ADC targeting CEACAM5
p p Read More

Company strengthens pipeline with AKTX-102 as it broadens its intellectual property estate

January 29, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 1,939 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy